Document is current
Any future updates will be listed below
-
Authors
Mathieu, Sylvain https://orcid.org/0000-0003-2017-3227
Riou, Charlotte https://orcid.org/0009-0000-4857-7763
Couderc, Marion https://orcid.org/0000-0002-2001-1132
Beauger, Marine https://orcid.org/0009-0002-8491-985X
Malochet-Guinamand, Sandrine https://orcid.org/0000-0003-3502-4689
Pickering, Marie-Eva https://orcid.org/0000-0001-6750-2038
Soubrier, Martin https://orcid.org/0000-0001-9349-0720
Tournadre, Anne https://orcid.org/0000-0002-5025-0214
- License Information
-
More Information
Article History
Received: 12 August 2025
Accepted: 4 October 2025
First Online: 23 October 2025
Declarations
:
: Sylvain Mathieu has received financial support from Bristol Myers Squibb, Pfizer, Abbvie, Novartis, Roche, Chugai, Merck, Sharp, Dohme, and Tilman, although unrelated to the submitted work. All other authors have no conflicts of interest to declare.
